Business, energy, technology, markets and global industry news from Business News Today

Cytovance Biologics

PharmaDeviceNews Cytovance Biologics
Cytovance Biologics is expanding its biologics development model with standalone analytical services covering method development, validation, GMP testing and stability programs without requiring a manufacturing contract. Representative image.
Pharma & Biotech

Cytovance widens biologics development offering after cell line and perfusion expansions

Cytovance Biologics opens GMP and non-GMP analytical testing without manufacturing contracts, widening its biologics development model.

Read More
Pharma & Biotech

Why Anixa Biosciences’ Phase 2 breast cancer vaccine push matters more than the manufacturing deal itself

Anixa Biosciences is advancing its breast cancer vaccine toward Phase 2 after positive Phase 1 data. Read what this means for oncology watchers.

Read More